Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Fecal microbial transplantation and fiber supplementation in patients with obesity and metabolic syndrome

FY 2018-19

Summary
This study is looking at the safety and effectiveness of stool transplant, also known as Fecal Microbiota Transplantation (FMT), and prebiotic supplementation in the management of metabolic syndrome. Metabolic syndrome is a common chronic progressive medical condition that is linked to obesity, diabetes, and heart disease. Obesity and metabolic syndrome are associated with abnormalities in gut flora which lead to a state of chronic inflammation. This chronic inflammation is thought to worsen the insulin resistance and heart disease seen with metabolic syndrome. Current treatment strategies have shown limited effect, are expensive, and have significant side effects with long-term use. FMT is a one-time treatment that has been shown to replace abnormal gut flora and improve metabolic disease by increasing anti-inflammatory short chain fatty acid (SCFA) production. However, the effects from FMT are not permanent because of the eventual depletion of SCFAs. Prebiotic supplementation has been demonstrated to sustain high SCFA levels, and is thus one strategy that may help to extend the benefits of FMT. At this point, we don’t know how FMT and prebiotics work together to affect SCFA levels in participants with metabolic syndrome. Our study will look at this interaction and help to answer if prebiotic therapy is effective in prolonging the benefits of FMT in participants with metabolic syndrome.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406326
Name
Mocanu Valentin
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Fecal microbial transplantation and fiber supplementation in patients with obesity and metabolic syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Fecal Microbial Transplant; Fiber; Gut Dysbiosis; Metabolic Syndrome; Metabolism; Microbiome; Obesity
Abstract
This study is looking at the safety and effectiveness of stool transplant, also known as Fecal Microbiota Transplantation (FMT), and prebiotic supplementation in the management of metabolic syndrome. Metabolic syndrome is a common chronic progressive medical condition that is linked to obesity, diabetes, and heart disease. Obesity and metabolic syndrome are associated with abnormalities in gut flora which lead to a state of chronic inflammation. This chronic inflammation is thought to worsen the insulin resistance and heart disease seen with metabolic syndrome. Current treatment strategies have shown limited effect, are expensive, and have significant side effects with long-term use. FMT is a one-time treatment that has been shown to replace abnormal gut flora and improve metabolic disease by increasing anti-inflammatory short chain fatty acid (SCFA) production. However, the effects from FMT are not permanent because of the eventual depletion of SCFAs. Prebiotic supplementation has been demonstrated to sustain high SCFA levels, and is thus one strategy that may help to extend the benefits of FMT. At this point, we don’t know how FMT and prebiotics work together to affect SCFA levels in participants with metabolic syndrome. Our study will look at this interaction and help to answer if prebiotic therapy is effective in prolonging the benefits of FMT in participants with metabolic syndrome.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mocanu, Valentin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~